Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.
Open | $5.240 |
Close | $5.075 |
Volume / Avg. | 3.746M / 2.288M |
Day Range | 4.980 - 5.470 |
52 Wk Range | 1.995 - 11.310 |
Market Cap | $749.082M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 18 |
Short Interest | 8.31% |
Days to Cover | 8.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocular Therapeutix (NASDAQ: OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Verona Pharma (NASDAQ:VRNA).
The latest price target for Ocular Therapeutix (NASDAQ: OCUL) was reported by HC Wainwright & Co. on Friday, April 19, 2024. The analyst firm set a price target for 16.00 expecting OCUL to rise to within 12 months (a possible 217.46% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $5.04 last updated April 22, 2024 at 7:39 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.